Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Hazard ratio of overall survival and risk of death, according to different clinical and histopathological characteristics

From: Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience

Univariate Analysis
Characteristic Hazard ratio 95% confidence interval p value
Age    
>60 years vs ≤60 years 2.1 1.01-4.38 0.046
No. of children    
0 vs 4+ 0.31 0.098-0.953 0.041
1-3 vs 4+ 0.30 0.18-0.86 0.02
1+ vs 0 1.81 0.63-5.2 0.27
Ethnicity    
Arabic vs Jewish 1.33 0.40-4.42 0.64
Family history    
Positive vs negative for breast cancer 0.96 0.42-2.17 0.92
Lymph nodes    
Positive vs negative 2.45 1.07-5.60 0.033
Tumor size    
>2 cm vs ≤2 cm 1.46 0.68-3.10 0.33
Surgery    
Mastectomy vs lumpectomy 1.45 0.63-3.33 0.38
Distant metastasis    
Yes vs no 7.06 3.27-15.28 <0.001
Multivariate Analysis
Characteristic 95% confidence interval p value
Age   
>60 years vs ≤60 years 1.335-14.986 0.015
No. of children   
0 vs 1+ 1.129-21.920 0.034